Notícias e Atividades da Turnstone Biologics

Turnstone Biologics é uma empresa listada sob o símbolo TSBX (US).

Veja o organograma con seus 13 executivos principais

Biografias mais buscadas da Turnstone Biologics

• Sammy Farah, President and Chief Executive Officer
• Jerel Davis, Chairman of the Board
• Kanya Rajangam, Director

Criar um alerta
para seguir os movimentos de executivos da Turnstone Biologics.

Turnstone Biologics possui 2.045 concorrentes concorrentes UnitedHealth Group (Estados Unidos), Siemens Healthineers (Alemanha) e Optum (Estados Unidos).

Popular M&A news in Saúde

• Navina acaba de anunciar uma arrecadação de fundos de 55 milhões de dólares. (publicado em 30 de março de 2025).
• Alcon has announced the acquisition of Lensar  (publicado em 25 de março de 2025).
• Mercalis and Mercalis have announced they will merge  (publicado em 18 de março de 2025)..

Outros contatos sugeridos na indústria do Saúde

• Ari Bousbib - Chairman and Chief Executive Officer da IQVIA
• Bryan Roberts - Director da Included Health
• Paulo Junqueira Moll - Chief Executive Officer da Rede D'Or Sao Luiz

Saiba mais sobre a indústria do Saúde >

Últimos comunicados de imprensa de Turnstone Biologics

• Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway | Turnstone Biologics
• Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer | Turnstone Biologics
• Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights | Turnstone Biologics
• Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights | Turnstone Biologics
• Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference | Turnstone Biologics
• Turnstone Biologics Appoints William Waddill to its Board of Directors | Turnstone Biologics
• News Releases | Turnstone Biologics
• Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights | Turnstone Biologics
• Turnstone Biologics to Participate in Upcoming Investor Conferences | Turnstone Biologics
• Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting | Turnstone Biologics
• View more press releases Close

Redes sociais sobre Turnstone Biologics

• Turnstone Biologics na Wikipedia, Google News e Yahoo Finance
• Turnstone Biologics na LinkedIn, Twitter e YouTube